#checkpoint_inhibition — Tuesday, March 17, 2026 (1 items)
| 0 | 💬 0 |
Dual PD-1/IL-2Ralpha targeting restores CD8(+) T cell fitness via STAT5/CD47 axis in SMARCA4-deficient NSCLC.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-03-17 | #cancer #immunotherapy #signaling #checkpoint_inhibition #t cell exhaustion |